An Assessment of Mistletoe-Based Drugs Work in Synergy with Radio-Chemotherapy in the Treatment of Glioma in vitro and in vivo in Glioblastoma Bearing Mice

In Europe, extracts from the mistletoe plant Viscum album L. (VE) have long been used in complementary cancer therapy. Several compounds, such as mistletoe lectins (ML) 1-3 and viscotoxins (VT), are contained in VE, as well as a few minor ingredients. ML-1 is thought to be the primary anti-tumor component of VE, VT causes cell…
Read more


March 11, 2021 0